BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 4

Guía de práctica clínica para el tratamiento del cáncer de próstata metastásico hormonosensible: guía en versión extensa
Clinical practice guideline for the treatment of metastatic hormone-sensitive prostate cancer: extended version guide

Peru. Seguro Social de Salud. Instituto de Evaluación e Investigación en Salud e Innovación.
El cáncer de próstata metastásico se presenta en el 20% de pacientes al momento del diagnóstico de cáncer de próstata (1). Los sitios comunes de diseminación metastásica locorregional son los ganglios linfáticos (99%) y huesos como pelvis, cadera y esqueleto axial (84%); mientras que las localiz...
Neoplasias da Próstata/diagnóstico por imagem, Neoplasias da Próstata/tratamento farmacológico, Metástase Neoplásica, Antineoplásicos/uso terapêutico, Drogas Antiandrogênicas não Esteroides/uso terapêutico
Texto completo

Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

England. National Institute for Health and Care Excellence.
This evaluation uses new cost-effectiveness estimates to update olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (NICE technology appraisal guidance TA831). No new clinical evidence was reviewed. Treatments for BRCA mutation-positive hormone-relapsed meta...
Neoplasias da Próstata/tratamento farmacológico, Mutação/efeitos dos fármacos, Proteína BRCA1, Antineoplásicos Hormonais/uso terapêutico
Texto completo

Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

England. National Institute for Health and Care Excellence.
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults. Commercial arrangement There is a simple discount patient access scheme for olaparib. NHS organisations can get details on the Commercial Access and ...
Neoplasias da Próstata/tratamento farmacológico, Proteína BRCA1, Mutação, Antineoplásicos/uso terapêutico
Texto completo

Prostate cancer: diagnosis and management

England. National Institute for Health and Care Excellence.
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people...
Neoplasias da Próstata/terapia, Neoplasias da Próstata/diagnóstico, Neoplasias da Próstata/tratamento farmacológico, Atenção Primária à Saúde/organização & administração, Saúde do Homem
Texto completo